Another clinical study found that supplementation with 1500 mg of green tea extract [856 mg of epigallocatechin gallate (EGCG)] for 16 weeks caused a significant reduction in fasting insulin, insulin resistance, and glycated hemoglobin in obese individuals with T2D [251]. This evidence concerns the gene INS and Insulin resistance.